Page last updated: 2024-12-11
xantocillin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
xantocillin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 5378293 |
| CHEMBL ID | 1977264 |
| SCHEMBL ID | 3773785 |
| SCHEMBL ID | 4264133 |
| MeSH ID | M0475772 |
Synonyms (55)
| Synonym |
|---|
| unii-06z55vz40d |
| 4-13-00-02885 (beilstein handbook reference) |
| xantocillin [inn:ban] |
| xantocilline |
| 06z55vz40d , |
| einecs 234-271-3 |
| unii-ex637i77pc |
| 11042-38-9 |
| ex637i77pc , |
| xantocilline [inn-french] |
| 1,4-di-p-oxyphenyl-2,3-di-isonitrilo-1,3-butadien |
| xantocillinum [inn-latin] |
| xanthocillinum |
| xantocillin [inn] |
| brn 3700094 |
| antibiotic obtained from cultures of penicillium notatum or the same substance produced by any other means |
| xantocilina [inn-spanish] |
| nsc-227183 |
| ophthocillin |
| ethylene isocyanide, bis(p-hydroxybenzylidene)- |
| brevicide-x |
| nsc-179485 |
| xantocillin |
| trianthil |
| phenol,4'-(2,3-diisocyano-1,3-butadiene-1,4-diyl)bis- |
| xanthocillin (x) |
| 1,3-di-isonitrilo-1,3-butadien |
| nsc227183 |
| xanthocillin x |
| nsc179485 |
| 580-74-5 |
| brevicide |
| brevicid |
| xantyrid |
| wln: qr d1uynu1&ynu1&u1r dq |
| xanthocillin |
| SCHEMBL3773785 |
| 4-[(1z,3z)-4-(4-hydroxyphenyl)-2,3-diisocyanobuta-1,3-dienyl]phenol |
| xantocillinum |
| xantocilina |
| CHEMBL1977264 |
| (1z, 3z)-2,3-diisocyano-1,4-bis(4-hydroxyphenyl)buta-1,3-diene |
| 4,4'-((1z,3z)-2,3-diisocyano-1,3-butadiene-1,4-diyl)bisphenol |
| xanthocillin x [mi] |
| 1,4-bis(p-hydroxyphenyl)-2,3-diisonitrilo-1,3-butadiene |
| xantocillin [who-dd] |
| (1z,3z)-2,3-diisocyano-1,4-bis(4-hydroxyphenyl)buta-1,3-diene |
| SCHEMBL4264133 |
| DTXSID801018149 |
| CS-0085072 |
| HY-122404 |
| brevicide, xanthocillin x |
| BS-1175 |
| 4,4'-((1z,3z)-2,3-diisocyanobuta-1,3-diene-1,4-diyl)diphenol |
| AKOS040742829 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (10)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 17.62
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.62) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 11 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||